Amicus Therapeutics CEO John Crowley
Goldman Sachs Talks
00:00
Introduction
John Crowley's involvement with biotechnology started in 19 98. Two of his children were diagnosed with pompey disease, a rare and often fatal disorder. He left his roll at bristol mire squib to join and found novazim therapeutics. Since two thousand and five he's been chairman and co of amichus Therapeutics.
Transcript
Play full episode
